Date:3/3/2010

="xn-location">the People's Republic of China ("PRC"), today announced that Mr. Yanqing Liu, the Company's CEO, and Mr. Stanley Hao, CFO, will present at the upcoming Rodman & Renshaw Annual China Investment Conference to be held on March 7-9, 2010.

    Presentation: March 8, 2010 at 12:45 p.m. in Ballroom III
    Location:     The Regent Hotel
                  99 Jinbao Street, Beijing, China

During the conference, Company management will be available for one-on-one meetings. The Rodman & Renshaw Annual China Investment Conference is a three-day event which features tracks devoted to Healthcare, Metals & Mining, Energy, Clean-tech, Asia, Community & Regional Banks, Growth, & Maritime. For more information about the conference, please visit http://www.rodm.com/conferences .

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufac
'/>"/>

SOURCE China Sky One Medical, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. China Baicaotang to Attend Rodman & Renshaw Annual China Investment Conference
2. China Medical Technologies Reports Third Fiscal Quarter Financial Results
3. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
4. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
5. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
6. China Sky One Medical Confirms Continued Sale of Seven of Eight Products on the Ministry of Healths Warning List
7. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
8. China Medical Technologies to Participate Investor Conferences in March 2010
9. China Biologic Products Responds to Allegations on Financial Websites
10. China Yongxin Pharmaceuticals Plans to Open Eighteen New Stores in 2010 to Further Expand Customer Base and Increase Market Share
11. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.